摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

cis-[PtCl2(CH3CN)(PPh3)] | 874271-93-9

中文名称
——
中文别名
——
英文名称
cis-[PtCl2(CH3CN)(PPh3)]
英文别名
cis-[PtCl2(NCCH3)(PPh3)];cis-[PtCl2(NCMe)(PPh3)];cis-[PtCl2(PPh3)(NCMe)];cis-[PtCl2(NCMe)(PPh3)];cis-[PtCl2(triphenylphosphine)(acetonitrile)];acetonitrile;dichloroplatinum;triphenylphosphane
cis-[PtCl<sub>2</sub>(CH<sub>3</sub>CN)(PPh<sub>3</sub>)]化学式
CAS
874271-93-9
化学式
C20H18Cl2NPPt
mdl
——
分子量
569.329
InChiKey
GNEAQLHKOSNOGR-UHFFFAOYSA-L
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    None
  • 重原子数:
    None
  • 可旋转键数:
    None
  • 环数:
    None
  • sp3杂化的碳原子比例:
    None
  • 拓扑面积:
    None
  • 氢给体数:
    None
  • 氢受体数:
    None

反应信息

  • 作为反应物:
    描述:
    cis-[PtCl2(CH3CN)(PPh3)]4,4'-联吡啶 作用下, 以 氯仿1,2-二氯乙烷 为溶剂, 反应 336.0h, 生成 (trans,trans)-[{PtCl2(PPh3)}2(μ-bipy)]
    参考文献:
    名称:
    铂(II)三苯基膦配合物与氮供体发散配体的反应性
    摘要:
    摘要通过使顺式[[PtCl2(PPh3)(NCMe)]反应制备了双核铂(II)配合物[{PtCl2(PPh3)} 2(μ-N–N)],其中N–N为发散的双齿氮配体。 (反式,反式)异构体以动力学产物形式获得,并以良好的收率和高纯度回收{1,NN =吡嗪(pyrz);2,NN = 4,4'-联吡啶(联吡啶);3,NN =哌嗪(pipz);4,NN =对二甲苯二胺(xylN2)}。顺式-[PtCl2(PPh3)(NCMe)]也与三齿发散配体2,4,6-三(-吡啶-4'-基)1,3,5-三嗪(py3TRIA)反应,摩尔比为3三核(反式,反式,反式)-[{PtCl2(PPh3)} 3(μ-py3TRIA)],5的形成。另一方面,顺式[PtCl2(PPh3)(NCMe)]的处理单齿吡啶(py)生成了反式[PtCl2(PPh3)(py)](6a)和顺式[PtCl2(PPh3)(py)](6b)的混合物。通过31P
    DOI:
    10.1016/j.poly.2016.09.016
  • 作为产物:
    描述:
    参考文献:
    名称:
    通过腈络合物制取 双核氯桥联铂(ii)衍生物的便捷途径†
    摘要:
    配合物的合成[PtCl 2(NCR)L] [R = Me,Et; L = PPh 3;R =的Et,L = PY,CO]和[氯铂酸{(κ 2 - P,Ç)P(OC 6 H ^ 4)(OPH)2 }(NCET)]中描述了从容易得到的[氯铂酸开始2(NCR )2 ]。讨论了产物在不同实验条件下的稳定性,以及它们作为双核络合物[Pt(μ-Cl)ClL] 2的前体的用途。的晶体和分子结构的顺式- [氯铂酸2(NCET)(PPH 3)],[SP-4-2] - [{氯铂酸(κ 2 - P,Ç)P(OC 6 H ^ 4)(OPH)2 }(NCET)〕和反式- [PT(μ-Cl)的{(κ 2 - P,Ç)P(OC 6 H ^ 4)(OPH)2 } ] 2个报告。
    DOI:
    10.1039/c1dt11709b
点击查看最新优质反应信息

文献信息

  • New trans dichloro (triphenylphosphine)platinum(II) complexes containing N -(butyl), N -(arylmethyl)amino ligands: Synthesis, cytotoxicity and mechanism of action
    作者:Lisa Dalla Via、Aída Nelly García-Argáez、Enzo Agostinelli、Daniela Belli Dell’Amico、Luca Labella、Simona Samaritani
    DOI:10.1016/j.bmc.2016.04.067
    日期:2016.7
    Some new platinum(II) complexes have been prepared, of general formula trans-[PtCl2(PPh3)NH(Bu)CH2Ar}], where the dimension of the Ar residue in the secondary amines has been varied from small phenyl to large pyrenyl group. The obtained complexes, tested in vitro towards a panel of human tumor cell lines showed an interesting antiproliferative effect on both cisplatin-sensitive and -resistant cells
    制备了一些新的通式为[-PtCl2(PPh3)NH(Bu)CH2Ar}]的(II)配合物,其中仲胺中Ar残基的大小从小基变为大large基团体。对一组人类肿瘤细胞系进行体外测试的所得复合物对顺铂敏感和耐药细胞均表现出令人感兴趣的抗增殖作用。对于最具细胞毒性的衍生物2a,其作用机理的研究突出了在抗性细胞上诱导细胞凋亡并有趣地抑制拓扑异构酶II催化活性的能力。
  • Synthesis and antiproliferative activity of ionic platinum(II) triphenylphosphino complexes
    作者:Daniela Belli Dell’ Amico、Luca Labella、Fabio Marchetti、Simona Samaritani、Gustavo Alejandro Hernández-Fuentes、Aída Nelly García-Argáez、Lisa Dalla Via
    DOI:10.1016/j.poly.2016.09.019
    日期:2016.11
    Abstract Ionic platinum(II) complexes [PtCl(PPh3)(L∧L)][BF4] L∧L = 2,2′-bipyridyl (1) 1,10-phenanthroline (2)} and [PtCl(PPh3)(L)2][BF4] L = pyridine (3), dimethyl sulfoxide (4)} were synthesized by dehalogenation of cis-[PtCl2(PPh3)(NCMe)], followed by reaction with the suitable ligand. Chelating nitrogen ligands L∧L afforded single products, which were structurally characterized. In the other cases
    摘要离子(II)配合物[PtCl(PPh3)(L∧L)] [BF4] L∧L= 2,2'-联吡啶(1)1,10-咯啉(2)}和[PtCl(PPh3) (L)2] [BF4] L =吡啶(3),二甲基亚砜(4)}是通过顺式-[PtCl2(PPh3)(NCMe)]卤并与合适的配体反应而合成的。螯合的配体L∧L提供了单一产物,其在结构上得到了表征。在其他情况下,在溶液中观察到几何异构体(L =吡啶)和/或配位异构体(L =二甲基亚砜)的混合物。在这些情况下,通过单晶X射线衍射获得难溶性异构体的结构。在体外测试了所有复合物对三种人类肿瘤细胞系MSTO-211H,HeLa和HepG2的抗增殖活性。
  • Clean oxidations by iodobenzene dichloride: Platinum(IV) complexes containing triphenylphosphine
    作者:Daniela Belli Dell' Amico、David Fioco、Luca Labella、Fabio Marchetti、Simona Samaritani
    DOI:10.1016/j.poly.2018.01.033
    日期:2018.5
    Abstract Neutral complexes with generic formula [PtCl2(PPh3)(L)] were efficiently oxidized to [PtCl4(PPh3)(L)] (L = dibenzylamine, p-toluidine, diethanolamine, pyridine and acetonitrile) using PhICl2 The anionic complex [TBA][PtCl3(PPh3)] (TBA = Tetrabutylammonium) was also oxidized to [TBA][PtCl5(PPh3)] with this method. The obtained products were fully characterized by 1H, 13C, 31P and 195Pt NMR
    摘要用PhICl2将具有通式[PtCl2(PPh3)(L)]的中性络合物有效化为[PtCl4(PPh3)(L)](L =二苄胺,对甲苯胺二乙醇胺吡啶乙腈)阴离子络合物[TBA该方法也将] [PtCl3(PPh3)](TBA =四丁基化为[TBA] [PtCl5(PPh3)]。所获得的产物通过1 H,13 C,31 P和195 Pt NMR,IR-ATR光谱,元素分析进行​​了充分表征,对于配合物顺式-[[PtCl4(PPh3)(对甲苯胺)]·CHCl3和反式-[PtCl4(PPh3) )(NCCH3)]·CH3CN,也通过单晶X射线衍射。
  • Platinum(II) complexes containing unsaturated ligands. Nucleophilic substitution versus nucleophilic attack to ligand: a stereochemistry driven outcome
    作者:Daniela Belli Dell’Amico、Claudio Broglia、Luca Labella、Fabio Marchetti、Daniele Mendola、Simona Samaritani
    DOI:10.1016/j.ica.2012.10.038
    日期:2013.1
    EtCN) towards diethylamine has been investigated. The processes are chemo- (substitution versus addition) and stereo-selective in dependence of the stereochemistry of the precursor. The structures of [SP4-4]-[PtCl(CONEt 2 )(NHEt 2 )(PPh 3 )], [SP4-4]- 1 , trans -[PtCl 2 (NHEt 2 )(PPh 3 )], trans - 2 , and cis -[PtCl 2 (E-)HN C(NEt 2 )Me}(PPh 3 )], cis - 3a , are reported.
    摘要混合配合物[PtCl 2(L)(L')](L = MeCN,EtCN,CO),L'= PPh 3的反应活性;L =η2 -C 2 H 4,CO; 已经研究了对二乙胺的L'= MeCN,EtCN)。取决于前体的立体化学,该过程是化学的(取代相对于加成)和立体选择性的。[SP4-4]-[PtCl(CONEt 2)(NHEt 2)(PPh 3)],[SP4-4] -1,反式-[PtCl 2(NHEt 2)(PPh 3)],反式-参见图2,并且报道了顺式-[PtCl 2 (E-)HN C(NEt 2)Me}(PPh 3)],顺式-3a。
  • Synthesis, antiproliferative and mitochondrial impairment activities of bis-alkyl-amino transplatinum complexes
    作者:Lisa Dalla Via、Aída N. García-Argáez、Arianna Adami、Silvia Grancara、Pamela Martinis、Antonio Toninello、Daniela Belli Dell’Amico、Luca Labella、Simona Samaritani
    DOI:10.1016/j.bmc.2013.09.025
    日期:2013.11
    A convenient synthetic route and the characterization of complexes trans-[PtCl2(L)(PPh3)] (L = Et2NH (2), (PhCH2)(2)NH (3), (HOCH2CH2)(2)NH) (4) are reported. The antiproliferative activity was evaluated on three human tumor cell lines. The investigation on the mechanism of action highlighted for the most active complex 4 the capacity to affect mitochondrial functions. In particular, both the induction of the mitochondrial permeability transition phenomenon and an aspecific membrane damage occurred, depending on concentration. (C) 2013 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫